Effect of transplanted adipose-derived stem cells in mice exhibiting idiopathic pulmonary fibrosis
Author(s) -
Hongbin Jiang,
Jun Zhang,
Zhemin Zhang,
Shengxiang Ren,
Chuansen Zhang
Publication year - 2015
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr.2015.4178
Subject(s) - pathology , idiopathic pulmonary fibrosis , pulmonary fibrosis , bleomycin , stem cell , lung transplantation , adipose tissue , transplantation , lung , immunohistochemistry , fibrosis , medicine , regeneration (biology) , cancer research , biology , chemotherapy , microbiology and biotechnology
Stem cell‑based cell therapy has provided a promising method for the treatment of pulmonary diseases, including idiopathic pulmonary fibrosis (IPF). Furthermore, adipose‑derived stem cells (ADSCs) have been reported to be effective in lung repair and regeneration. In the current study, IPF was induced in mice by intratracheal instillation of bleomycin (BLM), and ADSCs were delivered systemically into the mice via the tail vein to evaluate the effects of ADSC transplantation. The ADSC engraftment rate and morphometric changes in lung tissue samples in vivo were investigated by histochemistry and immunohistochemistry, as well as by western blotting. The results indicated that ADSCs may relieve IPF and provide a significant contribution to lung repair when administered at an early stage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom